SCHEMBL3267995

SCHEMBL3267995

Fc1ccc(-c2cccc(N3CCNCC3)c2)c(F)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 11/20 0.69
HTR1A P08908 9/20 0.69
HTR6 P50406 4/20 0.51
HTR2C P28335 3/20 0.49
ADRB1 P08588 3/20 0.49
HTR2A P28223 3/20 0.49
HTR3E A5X5Y0 2/20 0.49
HTR3B O95264 2/20 0.49
HTR3A P46098 2/20 0.49
HTR3D Q70Z44 2/20 0.49
HTR3C Q8WXA8 2/20 0.49
SIGMAR1 Q99720 2/20 0.49
THRB P10828 2/20 0.49
HTR1D P28221 2/20 0.49
HTR2B P41595 2/20 0.49
ALDH1A1 P00352 1/20 0.49
TP53 P04637 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15577989 0.82 HTR7 (1.00) HTR7HTR1AHTR6HTR2CADRB1
SCHEMBL3274862 0.81 HTR7 (0.63) HTR7HTR1AHTR6HTR2CADRB1
SCHEMBL6650883 0.81 HTR7 (0.59) HTR7HTR1AHTR6HTR2CADRB1
SCHEMBL3269200 0.81 FAAH (0.52) HTR7HTR1A
SCHEMBL315894 0.80 HTR7 (0.68) HTR7HTR1AHTR6HTR2CADRB1
Bromide SCHEMBL6774182 0.78 HTR7 (0.66) HTR7HTR1AHTR6HTR2CADRB1
Hydrochloric Acid SCHEMBL11556656 0.78 HTR7 (0.66) HTR7HTR1AHTR6HTR2CADRB1
Hydrochloric Acid SCHEMBL9743614 0.78 HTR7 (0.66) HTR7HTR1AHTR6HTR2CADRB1
SCHEMBL27580439 0.78 HTR7 (0.55) HTR7HTR1AHTR6HTR2CADRB1
Bromide SCHEMBL27376788 0.77 HTR7 (0.64) HTR7HTR1AHTR6HTR2CADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100234389-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-16 US disclosed
EP-2199282-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2010-06-23 EP disclosed
US-20090163508-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234389-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA HTR7 1437/4885HTR1A 1025/4885HTR6 1160/4885
US-20090163508-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA HTR7 1437/4885HTR1A 1025/4885HTR6 1160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.